Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 26.70
+0.10 (0.38%)
Feb 11, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 6.49 billion as of February 13, 2026. Its market cap has decreased by -22.10% in one year.
Market Cap
6.49B
Enterprise Value
6.14B
Revenue
1.28B
Ranking
n/a
PE Ratio
47.02
Stock Price
26.70
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.49B, an increase of 57.65%. That is a compound annual growth rate of 3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.49B | 2.10% |
| Dec 31, 2025 | 6.36B | -20.85% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YungShin Global Holding | 14.70B |
| Foresee Pharmaceuticals | 13.47B |
| Handa Pharmaceuticals | 12.18B |
| Standard Chemical & Pharmaceutical | 10.85B |
| Formosa Laboratories | 6.91B |
| SCI Pharmtech | 6.35B |
| Easywell Biomedicals | 3.99B |
| Orient EuroPharma | 3.83B |